03:48 PM EST - Covalon Technologies Ltd : Announced a licensing agreement with the University of Michigan's Center for Integrative Research in Critical Care, whereby Covalon has licensed intellectual property from MCIRCC that, when commercialized, could prevent or reduce the occurrence of Ventilator-Associated Pneumonia, a potentially devastating hospital acquired infection, and the most common nosocomial infection in critically ill patients. Covalon Technologies Ltd
shares V.COV are trading down $0.01 at $0.80.
